Figure 5.
NKG2C+CD57+FcεR1γ+ NK cells from recipients of TCD HCT with CMV reactivation exhibit greater effector response compared with NKG2C+CD57+FcεR1γ− NK cells. Comparing the effector function of (A) NKG2C+FcεR1γ+ vs NKG2C+FcεR1γ− of total NK cells, and (B) CD57+FcεR1γ+ vs CD57+FcεR1γ− of NKG2C+2A− NK cells derived from recipients of TCD HCT with CMV reactivation (n = 6). The gates in the dot plots represent NK cell populations that were analyzed for effector function. Percentages of CD107a (left) and IFN-γ (right) of indicated NK cell subpopulations are depicted. Two-way ANOVA with multiple comparisons were used for statistical analysis, with ∗P ≤ .05; ∗∗P ≤ .01; ∗∗∗P ≤ .001; ∗∗∗∗P ≤ .0001.

NKG2C+CD57+FcεR1γ+ NK cells from recipients of TCD HCT with CMV reactivation exhibit greater effector response compared with NKG2C+CD57+FcεR1γ NK cells. Comparing the effector function of (A) NKG2C+FcεR1γ+ vs NKG2C+FcεR1γ of total NK cells, and (B) CD57+FcεR1γ+ vs CD57+FcεR1γ of NKG2C+2A NK cells derived from recipients of TCD HCT with CMV reactivation (n = 6). The gates in the dot plots represent NK cell populations that were analyzed for effector function. Percentages of CD107a (left) and IFN-γ (right) of indicated NK cell subpopulations are depicted. Two-way ANOVA with multiple comparisons were used for statistical analysis, with ∗P ≤ .05; ∗∗P ≤ .01; ∗∗∗P ≤ .001; ∗∗∗∗P ≤ .0001.

Close Modal

or Create an Account

Close Modal
Close Modal